Delivery Order SPE2DB22D3301-SPE2DB24FX4QA

Award Date 10/30/23
Potential Completion Date 10/31/23
Potential Value $91K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $12,163.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical, which runs through November 2026. The contract is for the supply of GILENYA 0.5 MG CAPSULE 30S, a prescription medication. It has a...
This federal contract award, valued at $53,116.57, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of February 14, 2025. The contract covers the procurement of GILENYA 0.5 MG CAPSULE 30S, a medication used in the treatment of multiple sclerosis. As an Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $99,900.53 firm fixed-price delivery order is for the supply of GILENYA 0.5 MG CAPSULE 30S, a prescription medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., which serves as the primary vehicle for providing a...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,232.00 contract is for the supply of GILENYA 0.5 MG CAPSULE 30S, a specialty medication. The contract has a firm-fixed price pricing type and an ultimate completion date of July 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, valued at $78,517.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GILENYA 0.5 MG CAPSULE 30S, a specialty medication. The award is a Delivery Order contract with a Firm Fixed Price pricing type, with a period of performance through May 23, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,173.78 Firm Fixed Price Delivery Order contract is for the supply of GILENYA 0.5 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of December 22, 2023 and was awarded on December 21, 2023. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,566.21 firm fixed-price delivery order is for the supply of GILENYA 0.5 MG CAPSULE 30S, a specialty medication, to support military healthcare programs. The contract has an ultimate completion date of November 24, 2023 and does not include any set-aside designations, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of GILENYA 0.5 MG CAPSULE 30S, a medication. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $80,424.19 and a performance period through May 14, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $13,659.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of GILENYA 0.5 MG CAPSULE 30S, a prescription medication, to support military healthcare programs. The contract has a firm fixed-price delivery order type and an ultimate completion date of May 16, 2024. The award is not designated as a set-aside contract....
This federal contract award is a Delivery Order with a Firm Fixed Price pricing type, valued at $16,078.45, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of GILENYA 0.5 MG CAPSULE 30S, a specialty medication, with an ultimate completion date of June 26, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FX4QA
    Delivery Order

This federal contract award is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $90,558.22, is for the provision of GILENYA 0.5 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of October 31, 2023 and is a Firm Fixed Price contract. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor, and there are no major subcontractors mentioned. The DLA, a defense agency, is the funding agency for this contract, which supports the healthcare needs of military personnel, veterans, and other federal beneficiaries through the procurement of essential pharmaceutical and medical supplies.

Generated 5/12/25, 9:49 AM